Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I

WP Hausdorff, J Bryant, PR Paradiso… - Clinical Infectious …, 2000 - academic.oup.com
We analyzed> 70 recent data sets to compare the serogroups causing invasive
pneumococcal disease (IPD) with those represented in conjugate vaccine formulations. Five …

[HTML][HTML] Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada

DK Chen, A McGeer, JC de Azavedo… - New England Journal …, 1999 - Mass Medical Soc
Background Fluoroquinolones are now recommended for the treatment of respiratory tract
infections due to Streptococcus pneumoniae, particularly when the isolates are resistant to β …

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

WHB Demczuk, I Martin, A Griffith… - Canadian journal of …, 2013 - cdnsciencepub.com
The introduction of the 7-valent pneumococcal vaccine (PCV7) in Canada was very effective
in reducing invasive pneumococcal disease (IPD) in children; however, increases of non …

Streptococcus pneumoniae infection: a Canadian perspective

X Deng, D Church, OG Vanderkooi… - Expert review of anti …, 2013 - Taylor & Francis
Streptococcus pneumoniae infections have resulted in significant morbidity and mortality
worldwide in children and adults. In Canada, Streptococcus pneumoniae remains one of the …

Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020

MA Alford, JA Karlowsky, HJ Adam… - Journal of …, 2023 - academic.oup.com
Objectives To assess the antimicrobial susceptibility of 14 138 invasive Streptococcus
pneumoniae isolates collected in Canada from 2011 to 2020. Methods Antimicrobial …

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

JA Bettinger, DW Scheifele, JD Kellner, SA Halperin… - Vaccine, 2010 - Elsevier
Active surveillance was conducted by the 12 centers of the Canadian Immunization
Monitoring Program, Active from 2000–2007 in children 16 years of age and younger to …

Evolution of S treptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999

JL Di Fabio, E Castañeda, CI Agudelo… - The Pediatric …, 2001 - journals.lww.com
Background. Since 1993 the Pan American Health Organization has coordinated a
surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile …

Antimicrobial Resistance in Respiratory Tract Streptococcus pneumoniae Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

GG Zhanel, L Palatnick, KA Nichol… - Antimicrobial agents …, 2003 - Am Soc Microbiol
ABSTRACT A total of 6,991 unique patient isolates of Streptococcus pneumoniae were
collected from October 1997 to June 2002 from 25 medical centers in 9 of the 10 Canadian …

Surveillance for Invasive Streptococcus pneumoniae Disease among Hospitalized Children in Bangladesh: Antimicrobial Susceptibility and Serotype Distribution

SK Saha, A Naheed, S El Arifeen… - Clinical Infectious …, 2009 - academic.oup.com
Background. Vaccines offer the prospect of primary disease prevention of pneumococcal
disease in childhood. For introduction of such vaccines in developing countries, information …

Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada

SN Patel, A McGeer, R Melano, GJ Tyrrell… - Antimicrobial agents …, 2011 - Am Soc Microbiol
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections
(LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has …